Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about CYBN
Recent news which mentions CYBN
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
These 10 Biotech Companies Are Researching 9 Different Psychedelic-Based Substances
August 22, 2025
Tickers
ATAI
CMPS
CYBN
MNMD
Tags
MNMD
Stocks / Equities
Market News
From
TalkMarkets
'Big 5" Psychedelic-Based Biotech Stocks Up 34% YTD
August 19, 2025
Tickers
ATAI
CMPS
CYBN
GHRS
Tags
CYBN
GHRS
CMPS
From
TalkMarkets
Psychedelics Policy Is Shifting In Washington: Here's What One Biotech CEO Sees Coming
June 03, 2025
Tickers
CYBN
Tags
FDA
Psychedelics
CYBN
From
Benzinga
Ex-Gov't Foe Joins Trump, RFK Jr.'s HHS To Lead Psychedelics Policy: What It Means For Investors
May 24, 2025
Tickers
ATAI
CMPS
CYBN
MNMD
Tags
SEEL
Psychedelics
ATAI
From
Benzinga
MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday
February 13, 2025
Tickers
BROS
COOP
CSCO
CYBN
Tags
Markets
HUBS
CSCO
From
Benzinga
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
November 29, 2024
Tickers
AACG
CMPS
CYBN
MNMD
Tags
CMPS
CYBN
AACG
From
Motley Fool
Cybin Inc. Begins Phase 3 Trials, Betting Big On CYB003 To Treat Depression
November 13, 2024
Tickers
CYBN
Tags
neuropsychiatry company
Markets
Market News
From
Benzinga
EXCLUSIVE: Neuropsychiatry-Focused Cybin Secures First US Composition of Matter Patent For Preclinical CYB005 Phenethylamines Program
October 24, 2024
Tickers
CYBN
NEWS
Tags
Top Stories
Benzinga
Market/Moving Exclusives
From
Benzinga
Leadership Shake-Ups In Cannabis And Psychedelics: Maryland's Cannabis Chief Resigns, Costly Legal Battle In MA Drags On & More
September 06, 2024
Tickers
AAWH
CCC
CYBN
NEWS
Tags
Cannabis
CSE:AAWH
CSE:TGIF
From
Benzinga
CYBN Stock Earnings: Cybin Beats EPS for Q1 2024
August 09, 2024
Tickers
CYBN
Tags
NYSE:CYBN
Earnings Reports
Market News
From
InvestorPlace
EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
July 31, 2024
Tickers
ATAI
CMPS
CYBN
HAVLF
Tags
PATOO
CSE:HAVN
Exclusives
From
Benzinga
3 Biotech Stocks That Could Make Your Summer Unforgettable
July 30, 2024
Tickers
CYBN
GPCR
JEF
LLY
Tags
SNDX
CYBN
NASDAQ:GPCR,NYSEAMERICAN:CYBN,NYSE:LLY,NASDAQ:SNDX,NYSE:JEF
From
InvestorPlace
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
July 03, 2024
Tickers
ATAI
CYBN
GHRS
Tags
CYBN
GHRS
Stocks to Buy
From
InvestorPlace
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
July 02, 2024
Tickers
ATAI
CMPS
CYBN
Tags
Market News
Stocks to Buy
ATAI
From
InvestorPlace
CYBN Stock Earnings: Cybin Beats EPS for Q4 2023
June 26, 2024
Tickers
CYBN
Tags
CYBN
Market News
Earnings Reports
From
InvestorPlace
Biopharma Co. Cybin Reports $78M Loss Amid Accelerating Expansion In Psychedelic Therapies, Drug Development
June 26, 2024
Tickers
CYBN
Tags
Psychedelics
Earnings
CYBN
From
Benzinga
Latest Executive Cannabis Changes You Should Know About: Curaleaf, Planet 13 Elect Directors And More
June 18, 2024
Tickers
CURA
CURLF
CWBHF
CWEB
Tags
TILT
Movers & Shakers
CWEB
From
Benzinga
Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
June 05, 2024
Tickers
ATAI
CYBN
MDMA
MNMD
Tags
MNMD
General
ETFs
From
Benzinga
Pot Company Gets License To Open Psilocybin Service Center, The Sacred Mushroom, In Oregon
May 09, 2024
Tickers
ATAI
CMPS
CYBN
KAYS
Tags
Market News
Psilocybin Service Center/
Oregon Health Authority
From
Benzinga
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
March 30, 2024
Tickers
CMND
CMPS
CYBN
FLHLF
Tags
CYBN
HUGE
Psychedelics Research
From
Benzinga
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
March 26, 2024
Tickers
CLNN
CYBN
LIFE
Tags
CYBN
CLNN
LIFE
From
InvestorPlace
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
March 20, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
LSDI
TRUFF
Psychedelics Research
From
Benzinga
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private Placement
March 13, 2024
Tickers
CMPS
CYBN
MNMD
Tags
Market News
Cannabis
Biotech
From
Benzinga
3 High-Potential Penny Stocks to Turn $1000 into $1 million
March 10, 2024
Tickers
CYBN
GOEV
JOB
Tags
JOB
Stocks to Buy
GOEV
From
InvestorPlace
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
HUGE
Financing
DRUG
From
Benzinga
Cybin Inc. Q3 Earnings: Clinical Advances Amid Financial Loss
February 16, 2024
Tickers
CYBN
NEWS
Tags
Cannabis
Biotech
General
From
Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
Tickers
ATAI
AWKNF
CMND
CYBN
Tags
Psychedelic Research
MNMD
Cannabis
From
Benzinga
Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
January 27, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
psilocybin therapies
PSIL
DRUG
From
Benzinga
FDA Green Lights Cybin's Psychedelic Clinical Study Assessing Generalized Anxiety
January 23, 2024
Tickers
CYBN
NEWS
Tags
Cannabis
DMT Analog
Market News
From
Benzinga
Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More
January 15, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Psychedelics Reform
Cannabis
LOBEF
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.